240 related articles for article (PubMed ID: 19171452)
1. In vitro and in vivo effect of IFNalpha on B16F10 melanoma in two models: subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice).
Martínez Conesa C; Alvarez Sánchez N; Vicente Ortega V; García Reverte J; Pascual Carpe F; Campos Aranda M
Biomed Pharmacother; 2009 May; 63(4):305-12. PubMed ID: 19171452
[TBL] [Abstract][Full Text] [Related]
2. Experimental model of pulmonary metastasis treatment with IFNalpha.
Martínez C; Vicente V; Yáñez MJ; García JM; Canteras M; Alcaraz M
Cancer Lett; 2005 Jul; 225(1):75-83. PubMed ID: 15922859
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of diosmin and interferon-alpha on metastatic pulmonary melanoma.
Alvarez N; Vicente V; Martínez C
Cancer Biother Radiopharm; 2009 Jun; 24(3):347-52. PubMed ID: 19538057
[TBL] [Abstract][Full Text] [Related]
4. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
5. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
[TBL] [Abstract][Full Text] [Related]
6. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis.
Kang IC; Kim DS; Jang Y; Chung KH
Biochem Biophys Res Commun; 2000 Aug; 275(1):169-73. PubMed ID: 10944460
[TBL] [Abstract][Full Text] [Related]
7. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic uveal melanoma. Development of neoadjuvant treatment in animal experiments].
Dithmar S; Adams AW; Rusciano D; Grossniklaus HE
Ophthalmologe; 2001 Aug; 98(8):761-5. PubMed ID: 11552416
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
[TBL] [Abstract][Full Text] [Related]
10. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
11. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma.
Liu X; Chan SY; Ho PC
Cancer Chemother Pharmacol; 2008 Dec; 63(1):167-74. PubMed ID: 18465132
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects in vitro and in vivo and mechanisms of protection against melanoma B16F10-Nex2 cells by fastuosain, a cysteine proteinase from Bromelia fastuosa.
Guimarães-Ferreira CA; Rodrigues EG; Mortara RA; Cabral H; Serrano FA; Ribeiro-dos-Santos R; Travassos LR
Neoplasia; 2007 Sep; 9(9):723-33. PubMed ID: 17898868
[TBL] [Abstract][Full Text] [Related]
14. Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro.
Zhang W; Lu Y; Xu B; Wu J; Zhang L; Gao M; Zheng S; Wang A; Zhang C; Chen L; Lei N
Cancer Biol Ther; 2009 Aug; 8(15):1489-99. PubMed ID: 19483477
[TBL] [Abstract][Full Text] [Related]
15. Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells.
Gude RP; Menon LG; Rao SG
J Exp Clin Cancer Res; 2001 Jun; 20(2):287-92. PubMed ID: 11484989
[TBL] [Abstract][Full Text] [Related]
16. BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice.
Wang H; Ke M; Tian Y; Wang J; Li B; Wang Y; Dou J; Zhou C
Eur J Pharmacol; 2013 May; 707(1-3):1-10. PubMed ID: 23541725
[TBL] [Abstract][Full Text] [Related]
17. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.
Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y
Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392
[TBL] [Abstract][Full Text] [Related]
18. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.
Ben Reguiga M; Bouquet C; Farinotti R; Bonhomme-Faivre L
Life Sci; 2012 Oct; 91(17-18):843-51. PubMed ID: 23047021
[TBL] [Abstract][Full Text] [Related]
20. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Ji MK; Shi Y; Xu JW; Lin X; Lin JY
Anticancer Drugs; 2013 Jun; 24(5):461-72. PubMed ID: 23442578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
